Crossmark

Integrating rare genetic variants into pharmacogenetic drug response predictions

Crossref DOI link: https://doi.org/10.1186/s40246-018-0157-3

Published Online: 2018-05-25

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ingelman-Sundberg, Magnus

Mkrtchian, Souren

Zhou, Yitian

Lauschke, Volker M. https://orcid.org/0000-0002-1140-6204
Funding

Funding for this research was provided by:

Vetenskapsrådet (2015-02760, 2016-01153, 2016-01154)

H2020 European Research Council (668353)

Lennart Philipson Foundation (2017)
License Information

Text and Data Mining valid from 2018-05-25
More Information

Article History

Received: 6 March 2018

Accepted: 8 May 2018

First Online: 25 May 2018

Ethics approval and consent to participate

: In this study, only publically available, anonymized data released under the Fort Lauderdale Agreement was analyzed, and thus, separate ethical approval was not required.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.